Key result
Weight loss after gastric banding lowers NT-proBNP by ~40% but levels remain above normal.
Why the study?
Does laparoscopic adjustable gastric banding reduce NT-proBNP levels in morbidly obese patients?
Cohort (n=34)
Does laparoscopic adjustable gastric banding reduce NT-proBNP levels in morbidly obese patients?
Absolute Event Rate: 204.87% vs 341.15%
p-value: p=<0.00001
Weight loss following laparoscopic adjustable gastric banding significantly reduces NT-proBNP levels in morbidly obese patients, though levels remain higher than in normal-weight controls.
No takes yet. Share an insight, caveat, or question.
Weight loss after gastric banding lowers NT-proBNP in obesity; supports biomarker response but leaves outcome benefits open for confirmation.
Hanusch‐Enserer et al. (2003) conducted a cohort in Morbid obesity (n=34). Laparoscopic adjustable gastric banding vs. Baseline (before surgery) and normal-weight controls was evaluated on NT-proBNP concentration (p=<0.00001). Weight loss after laparoscopic adjustable gastric banding significantly decreased NT-proBNP concentrations from 341.15 to 204.87 fmol/mL (p<0.00001), though levels remained higher than in normal-weight controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: